WhiteOak Capital Pharma and Healthcare Fund Growth Return

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
This Fund:
Sensex:
BankFD:

Showing Funds Performance since Sep 07, 2020

WhiteOak Capital Pharma and Healthcare Fund Growth Fund Overview

Min. investment

SIP ₹100 & Lump. ₹500

AUM (Fund size)

₹825 Cr

Lock In Period

N/A

Expense Ratio

2.84

Exit Load

Nil

Benchmark

BSE Healthcare Total Return

WhiteOak Capital Pharma and Healthcare Fund Growth Calculate Returns

You would have got

close_grey_icon
No Data Found
Your Investment Amount
  • 1
  • 2
  • 3
  • 4
  • 5

Growth Review

DurationFund Return(%)Category Average(%)Category Best(%)
1M4.130.786.25
6M23.983.0826.11
1Y20.115.9024.98
3Y0.0015.5293.42

Portfolio Analysis

  • Equity: 94.48%
  • Debt: 5.52%
  • Others
As on: 2026-07-31
View allocation % by

1. Sun Pharmaceutical Industries Limited8.53%
2. Torrent Pharmaceuticals Limited7.81%
3. Laurus Labs Limited4.94%
4. Divi's Laboratories Limited3.86%
5. Cipla Limited3.72%
6. Sai Life Sciences Limited3.18%
7. Zydus Lifesciences Limited2.94%
8. Neuland Laboratories Limited2.87%
9. Corona Remedies Limited2.44%
10. Aurobindo Pharma Limited2.42%
11. Ajanta Pharma Limited1.81%
12. Procter & Gamble Health Limited1.70%
13. Granules India Limited1.56%
14. Anthem Biosciences Limited1.47%
15. Acutaas Chemicals Limited1.44%
16. Onesource Specialty Pharma Limited1.18%
17. IPCA Laboratories Limited1.12%
18. Innova Captab Limited1.10%
19. Pfizer Limited1.03%
20. Gland Pharma Limited0.91%
21. Senores Pharmaceuticals Limited0.85%
22. Aarti Pharmalabs Limited0.85%
23. Supriya Lifescience Limited0.60%
24. Biocon Limited0.54%
25. Zota Health Care Limited0.45%
26. Sudeep Pharma Limited0.37%
27. Orchid Pharma Limited0.27%
28. Cohance Lifesciences Limited0.21%

1. Apollo Hospitals Enterprise Limited4.78%
2. Max Healthcare Institute Limited3.76%
3. Dr. Lal Path Labs Limited2.53%
4. Krishna Institute Of Medical Sciences Limited2.34%
5. Fortis Healthcare Limited2.20%
6. Thyrocare Technologies Limited2.20%
7. Narayana Hrudayalaya Limited1.82%
8. Rainbow Childrens Medicare Limited1.61%
9. Vijaya Diagnostic Centre Limited1.54%
10. Global Health Limited1.18%
11. Jupiter Life Line Hospitals Limited1.07%
12. Manipal Health Enterprises Ltd.0.97%
13. Kovai Medical Center and Hospital Limited0.95%
14. Nephrocare Health Services Ltd0.67%

1. Aether Industries Limited1.47%
2. Tatva Chintan Pharma Chem Limited0.47%

1. Navin Fluorine International Limited1.46%

1. Shaily Engineering Plastics Limited1.39%

1. Poly Medicure Limited0.91%
2. Laxmi Dental Limited0.23%
No Data Found
No Data Found

About Fund WhiteOak Capital Pharma and Healthcare Fund Growth

WhiteOak Capital Pharma and Healthcare Fund Growth managed by WhiteOak Capital Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹825 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 2.84. Under the expert guidance of Ramesh Mantri ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.

Fund Managers

Ramesh Mantri

Mr. Ramesh Mantri holds MBA, CFA and CA. His prior assignments include White Oak Capital Management LLP, Ashoka Capital Advisers, Smith Management-Mumbai Office and CRISIL.

Peer Comparison

Fund NameRatingsAUMExpense Ratio
WhiteOak Capital Pharma and Healthcare Fund Growth0824 CR2.84
SBI Healthcare Opportunities Fund Growth35,399 CR2
UTI Healthcare Fund Growth31,370 CR2.22
Fund Name1Y3Y
This FundWhiteOak Capital Pharma and Healthcare Fund Growth20.11280
This FundSBI Healthcare Opportunities Fund Growth20.034587.4845
This FundUTI Healthcare Fund Growth15.692987.7124

WhiteOak Capital Pharma and Healthcare Fund Growth FAQs

WhiteOak Capital Pharma and Healthcare Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.

The expense ratio of WhiteOak Capital Pharma and Healthcare Fund Growth is 2.84. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.

WhiteOak Capital Pharma and Healthcare Fund Growth’s fund performance is as follows:
  • 1 Month : 4.13%
  • 6 Months : 23.98%
  • 1 Year : 20.11%
  • 3 Years : 0.00%
Returns of WhiteOak Capital Pharma and Healthcare Fund Growth are updated daily based on NAV of ₹ 16.782 as on Aug 14,2026. Since inception, the return has been 0.00%.

You can invest in WhiteOak Capital Pharma and Healthcare Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.

The fund size (AUM) of WhiteOak Capital Pharma and Healthcare Fund Growth is ₹825 crore. It changes based on market performance, inflows, and outflows.

You can track your investment in WhiteOak Capital Pharma and Healthcare Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.